VERTEX Company Profile
✉ Email this page to a colleague
What is the competitive landscape for VERTEX
VERTEX has ten approved drugs.
There are seventy-seven US patents protecting VERTEX drugs.
There are eight hundred and forty-eight patent family members on VERTEX drugs in fifty-three countries and ninety-two supplementary protection certificates in twenty countries.
Summary for VERTEX
| International Patents: | 848 |
| US Patents: | 77 |
| Tradenames: | 7 |
| Ingredients: | 7 |
| NDAs: | 10 |
| Patent Litigation for VERTEX: | See patent lawsuits for VERTEX |
| PTAB Cases with VERTEX as patent owner: | See PTAB cases with VERTEX as patent owner |
Drugs and US Patents for VERTEX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vertex Pharms Inc | ORKAMBI | ivacaftor; lumacaftor | GRANULE;ORAL | 211358-003 | Sep 2, 2022 | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Vertex Pharms Inc | KALYDECO | ivacaftor | GRANULE;ORAL | 207925-002 | Mar 17, 2015 | RX | Yes | Yes | 8,324,242*PED | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Vertex Pharms Inc | SYMDEKO (COPACKAGED) | ivacaftor; ivacaftor, tezacaftor | TABLET;ORAL | 210491-002 | Jun 21, 2019 | RX | Yes | No | 11,564,916 | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for VERTEX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Vertex Pharms Inc | KALYDECO | ivacaftor | GRANULE;ORAL | 207925-001 | Mar 17, 2015 | 8,629,162 | ⤷ Start Trial |
| Vertex Pharms Inc | TRIKAFTA (COPACKAGED) | elexacaftor, ivacaftor, tezacaftor; ivacaftor | GRANULES;ORAL | 217660-001 | Apr 26, 2023 | 8,629,162 | ⤷ Start Trial |
| Vertex Pharms Inc | KALYDECO | ivacaftor | GRANULE;ORAL | 207925-004 | May 3, 2023 | 8,629,162 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Premature patent expirations for VERTEX
Expiration due to failure to pay maintenance fee
| Patent Number | Expiration Date |
|---|---|
| ⤷ Start Trial | ⤷ Start Trial |
International Patents for VERTEX Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 6063455 | ⤷ Start Trial |
| Croatia | P20210208 | ⤷ Start Trial |
| Cyprus | 1116979 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for VERTEX Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1773816 | 1590036-8 | Sweden | ⤷ Start Trial | PRODUCT NAME: N-(5-HYDROXY-2,4-DITERT-BUTYL-PHENYL)-4-OXO-1H-QUINOLINE-3- CARBOXAMIDE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEROF; REG. NO/DATE: EU/1/12/782/001 20120725 |
| 3170818 | 202040032 | Slovenia | ⤷ Start Trial | PRODUCT NAME: COMBINATION (A) 3-(6-(1-(2,2-DIFLUOROBENZO (D)(1,3)DIOXOL-5-YL)CYCLOPROPANCARBOXAMIDO)-3-METHYLPYRIDIN-2-YL) BENZOIC ACID IN (B) N-(5-HYDROXY-2,4-DI TERT-BUTYL-PHENYL)-4-OXO-1H-QUINOLINE-3-CARBOXAMIDE OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS; NATIONAL AUTHORISATION NUMBER: EU/1/15/1059; DATE OF NATIONAL AUTHORISATION: 20151119; AUTHORITY FOR NATIONAL AUTHORISATION: EU |
| 3170818 | PA2020525 | Lithuania | ⤷ Start Trial | PRODUCT NAME: (A) 3-(6-(1-(2,2-DIFLUORBENZO(D)(1,3)DIOKSOL-5-IL)CIKLOPROPANKARBOKSAMIDO)-3-METILPIRIDIN-2-IL)BENZENKARBOKSIRUGSTIES IR (B) N-(5-HIDROKSI-2,4-DITERT-BUTIL-FENIL)-4-OKSO-1H-CHINOLIN-3-KARBOKSAMIDO ARBA JO FARMACINIU POZIURIU PRIIMTINOS DRUSKOS DERINYS; REGISTRATION NO/DATE: EU/1/15/1059 20151119 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
